Suppr超能文献

雌二醇通过 ABCC1 和 ABCG2 诱导乳腺癌细胞中鞘氨醇 1-磷酸的输出。

Estradiol induces export of sphingosine 1-phosphate from breast cancer cells via ABCC1 and ABCG2.

机构信息

From the Division of Surgical Oncology, Massey Cancer Center, Virginia Commonwealth University School ofMedicine, Richmond, Virginia 23298, USA.

出版信息

J Biol Chem. 2010 Apr 2;285(14):10477-86. doi: 10.1074/jbc.M109.064162. Epub 2010 Jan 28.

Abstract

Sphingosine 1-phosphate (S1P), a potent sphingolipid mediator produced by sphingosine kinase isoenzymes (SphK1 and SphK2), regulates diverse cellular processes important for breast cancer progression acting in an autocrine and/or paracrine manner. Here we show that SphK1, but not SphK2, increased S1P export from MCF-7 cells. Whereas for both estradiol (E(2)) and epidermal growth factor-activated SphK1 and production of S1P, only E(2) stimulated rapid release of S1P and dihydro-S1P from MCF-7 cells. E(2)-induced S1P and dihydro-S1P export required estrogen receptor-alpha, not GPR30, and was suppressed either by pharmacological inhibitors or gene silencing of ABCC1 (multidrug resistant protein 1) or ABCG2 (breast cancer resistance protein). Inhibiting these transporters also blocked E(2)-induced activation of ERK1/2, indicating that E(2) activates ERK via downstream signaling of S1P. Taken together, our findings suggest that E(2)-induced export of S1P mediated by ABCC1 and ABCG2 transporters and consequent activation of S1P receptors may contribute to nongenomic signaling of E(2) important for breast cancer pathophysiology.

摘要

鞘氨醇 1-磷酸(S1P)是一种由鞘氨醇激酶同工酶(SphK1 和 SphK2)产生的有效的鞘脂类介质,以自分泌和/或旁分泌的方式调节乳腺癌进展中多种重要的细胞过程。在这里,我们表明 SphK1 但不是 SphK2 增加了 MCF-7 细胞中 S1P 的外排。尽管雌二醇(E(2))和表皮生长因子激活的 SphK1 和 S1P 的产生,但只有 E(2)刺激 MCF-7 细胞中 S1P 和二氢-S1P 的快速释放。E(2)诱导的 S1P 和二氢-S1P 外排需要雌激素受体-α,而不是 GPR30,并且可以通过药理学抑制剂或 ABCC1(多药耐药蛋白 1)或 ABCG2(乳腺癌耐药蛋白)的基因沉默来抑制。抑制这些转运体也阻断了 E(2)诱导的 ERK1/2 激活,表明 E(2)通过 S1P 的下游信号转导激活 ERK。总之,我们的研究结果表明,E(2)诱导的由 ABCC1 和 ABCG2 转运体介导的 S1P 外排以及随后的 S1P 受体激活可能有助于 E(2)对乳腺癌病理生理学重要的非基因组信号传导。

相似文献

引用本文的文献

1
Advances in ORMDL Research in Malignant Tumors: A Review.恶性肿瘤中ORMDL研究进展:综述
Onco Targets Ther. 2025 Jul 28;18:821-832. doi: 10.2147/OTT.S537194. eCollection 2025.

本文引用的文献

5
ABC transporters, drug resistance, and cancer stem cells.ABC转运蛋白、耐药性与癌症干细胞
J Mammary Gland Biol Neoplasia. 2009 Mar;14(1):3-9. doi: 10.1007/s10911-009-9109-9. Epub 2009 Feb 18.
6
ABCG2: a perspective.ABCG2:一种观点。
Adv Drug Deliv Rev. 2009 Jan 31;61(1):3-13. doi: 10.1016/j.addr.2008.11.003. Epub 2008 Dec 16.
10
Targeting SphK1 as a new strategy against cancer.将鞘氨醇激酶1作为抗癌新策略的靶向治疗。
Curr Drug Targets. 2008 Aug;9(8):662-73. doi: 10.2174/138945008785132402.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验